ACAD
47.7
-0.49
-1.02%
AEMD
9.7
+0.2
+2.11%
APRI
1.4
+0.02
+1.45%
ARNA
4.05
-0.01
-0.25%
ATEC
1.36
0.00
0.00%
CNAT
4.41
-0.08
-1.78%
CRXM
0.29
-0.01
-3.33%
CYTX
0.421
-0.005
-1.290%
DXCM
84.93
+0.4
+0.47%
GNMK
8.12
+0.08
+1.00%
HALO
23.31
+0.28
+1.22%
ILMN
214.31
-2.39
-1.10%
INNV
0.158
+0.003
+1.935%
INO
7.15
-0.1
-1.38%
ISCO
0.043
0.00
0.00%
ISIS
55.3
+1.34
+2.48%
LGND
109.31
+0.57
+0.52%
LPTN
0.252
-0.013
-4.8430%
MBVX
1.9
-0.11
-5.47%
MEIP
1.49
0.00
0.00%
MNOV
3.63
-0.1
-2.68%
MRTX
27.82
-0.14
-0.50%
MSTX
0.424
-0.006
-1.441%
NBIX
49.56
+0.57
+1.16%
NUVA
55.58
+0.39
+0.71%
ONCS
5.79
-0.19
-3.18%
ONVO
3.19
-0.16
-4.78%
OREX
3.86
-0.1
-2.53%
OTIC
25.23
-0.74
-2.85%
QDEL
20.85
+0.23
+1.12%
RCPT
228
-0.56
-0.25%
RGLS
7.77
-0.22
-2.75%
RMD
55.9
+0.5
+0.90%
SCIE
0.016
-0.002
-10.5556%
SPHS
0.802
-0.042
-4.976%
SRNE
20.75
-0.42
-1.98%
TROV
7.5
-0.38
-4.82%
VICL
0.65
+0.022
+3.4873%
ZGNX
19.49
-0.11
-0.56%
ACAD
47.7
-0.49
-1.02%
AEMD
9.7
+0.2
+2.11%
APRI
1.4
+0.02
+1.45%
ARNA
4.05
-0.01
-0.25%
ATEC
1.36
0.00
0.00%
CNAT
4.41
-0.08
-1.78%
CRXM
0.29
-0.01
-3.33%
CYTX
0.421
-0.005
-1.290%
DXCM
84.93
+0.4
+0.47%
GNMK
8.12
+0.08
+1.00%
HALO
23.31
+0.28
+1.22%
ILMN
214.31
-2.39
-1.10%
INNV
0.158
+0.003
+1.935%
INO
7.15
-0.1
-1.38%
ISCO
0.043
0.00
0.00%
ISIS
55.3
+1.34
+2.48%
LGND
109.31
+0.57
+0.52%
LPTN
0.252
-0.013
-4.8430%
MBVX
1.9
-0.11
-5.47%
MEIP
1.49
0.00
0.00%
MNOV
3.63
-0.1
-2.68%
MRTX
27.82
-0.14
-0.50%
MSTX
0.424
-0.006
-1.441%
NBIX
49.56
+0.57
+1.16%
NUVA
55.58
+0.39
+0.71%
ONCS
5.79
-0.19
-3.18%
ONVO
3.19
-0.16
-4.78%
OREX
3.86
-0.1
-2.53%
OTIC
25.23
-0.74
-2.85%
QDEL
20.85
+0.23
+1.12%
RCPT
228
-0.56
-0.25%
RGLS
7.77
-0.22
-2.75%
RMD
55.9
+0.5
+0.90%
SCIE
0.016
-0.002
-10.5556%
SPHS
0.802
-0.042
-4.976%
SRNE
20.75
-0.42
-1.98%
TROV
7.5
-0.38
-4.82%
VICL
0.65
+0.022
+3.4873%
ZGNX
19.49
-0.11
-0.56%
Home » Archive by Category

Xconomy

In Venture Reinvention, Versant Sees Gains Amid Biotech Boom Times

April 28, 2015 – 11:46 pm

There’s not much ice in San Francisco, where I grew up, so hockey metaphors often go right over my head. But I can’t resist noting that Versant Ventures, led by a former hockey player,…

[[Click headline to continue reading.]]

In Venture Reinvention, Versant Sees Gains Amid Biotech Boom Times

April 28, 2015 – 11:46 pm

There’s not much ice in San Francisco, where I grew up, so hockey metaphors often go right over my head. But I can’t resist noting that Versant Ventures, led by a former hockey player,…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Juno, Genervon, Tekmira, DNANexus & More

April 23, 2015 – 3:15 pm

The West Coast this week is home to news about a new immuno-oncology combination, a tiny step forward in Ebola, and a whole lot of hullabaloo over a tiny L.A. biotech developing a drug for Lou…

[[Click headline to continue reading.]]

Innovation Grants and Unsung Life Sciences Startups of San Diego

April 22, 2015 – 9:01 pm

It comes as no surprise that federal grants for innovative research or technology transfer have become a lifeline for many early stage life sciences startups in the San Diego area. What may be…

[[Click headline to continue reading.]]

Napa Summit 2015: Request Your Invite to Xconomy’s Most Elite Event

April 22, 2015 – 8:44 am

What are the forces shaping our innovation future—and who are the leaders who will build it? We can’t promise all the answers, but we can promise an unusually intimate and inspiring discussion…

[[Click headline to continue reading.]]

Gene Therapy Upstart Dimension Nabs $65M From “Crossover” Backers

April 21, 2015 – 6:16 am

The race is on to be the first to market with a gene therapy for hemophilia. And one of the entrants just got a big round of funding in what looks like a prelude to an initial public offering….

[[Click headline to continue reading.]]

Intel, Edico Genome Working to Speed Analysis of Genomic Data

April 21, 2015 – 5:00 am

As some 3,000 experts in genomics and bioinformatics gather in Boston this morning for the opening of the 2015 Bio-IT World Conference & Expo, San Diego’s Edico Genome announced it has forged a…

[[Click headline to continue reading.]]

Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study

April 21, 2015 – 2:55 am

Alnylam Pharmaceuticals been saying for a few years now that its lead RNA interference drug can reduce the levels of a protein responsible for a rare, crippling nerve condition known as familial…

[[Click headline to continue reading.]]

San Diego First-Quarter VC Funding Hits $270M & Top 10 Deals

April 20, 2015 – 9:00 am

Venture funding for software staged a comeback in San Diego during the first quarter, with investments classified as software deals accounting for nearly $110 million, or 40 percent of the $270…

[[Click headline to continue reading.]]

Dip, But No Slowdown in First-Quarter VC Funding, & Top 10 Deals

April 16, 2015 – 9:01 pm

A new MoneyTree Report being released today shows that U.S. venture capital activity eased off during the first three months of 2015. Yet it still marked the fifth consecutive quarter in which U.S….

[[Click headline to continue reading.]]